GALT · Galectin Therapeutics Inc · Documents
$3.19
-0.19 (-5.62%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of 12 months from the issuance date of these financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$321.71M
Shares
100.85M
Volume · Oct 23
195.22K
Avg daily vol (3M)
303.16K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2021-05-17 | — | |
| 8-K | — | 2021-04-19 | 2021-04-16 | |
| 10-K | — | 2021-03-31 | 2020-12-31 | |
| 8-K | — | 2021-03-31 | — | |
| 8-K | — | 2021-03-09 | — | |
| 8-K | — | 2020-12-07 | 2020-12-03 | |
| 8-K | — | 2020-12-03 | — | |
| 8-K | — | 2020-11-09 | — | |
| 10-Q | — | 2020-11-09 | 2020-09-30 | |
| DEF 14A | — | 2020-10-19 | 2020-12-03 | |
| 8-K | — | 2020-09-29 | — | |
| 8-K | — | 2020-09-22 | — | |
| 8-K | — | 2020-09-02 | 2020-08-31 | |
| 8-K | — | 2020-08-10 | — | |
| 10-Q | — | 2020-08-10 | 2020-06-30 | |
| 8-K | — | 2020-06-30 | — | |
| 8-K | — | 2020-06-26 | 2020-06-22 | |
| 10-Q | — | 2020-05-11 | 2020-03-31 | |
| S-3 | — | 2020-05-11 | — | |
| 8-K | — | 2020-05-11 | — | |
| 8-K | — | 2020-04-30 | — | |
| 8-K | — | 2020-03-17 | 2020-03-12 | |
| 10-K | — | 2020-03-16 | 2019-12-31 | |
| 8-K | — | 2020-03-16 | — | |
| 8-K | — | 2020-02-20 | 2020-02-19 |
Showing 101–125 of 125 filings
Key facts
CIK
1133416
CUSIP
363225202
13F (30d)
15 filings
15 filers
Visit website
Investor relations